Jul 9, 2008 - Znomics, Inc. (OTCBB:ZNOM), a pioneer in the development of the zebrafish as a vertebrate genetic platform to accelerate drug discovery, announced a collaborative research program with Oregon Health & Science University (OHSU) and Thomas Scanlan, Ph.D., Director of its Chemical Biology Program, to design and develop pre-clinical compounds to treat diseases such as rheumatoid arthritis, asthma and inflammatory bowel syndrome... Znomics' Press Release -
Showing posts with label Znomics. Show all posts
Showing posts with label Znomics. Show all posts
Jul 14, 2008
Znomics Launches Drug Discovery Program for Treatment of Inflammatory Diseases with Leading Chemist at Oregon Health & Science University
Jul 9, 2008 - Znomics, Inc. (OTCBB:ZNOM), a pioneer in the development of the zebrafish as a vertebrate genetic platform to accelerate drug discovery, announced a collaborative research program with Oregon Health & Science University (OHSU) and Thomas Scanlan, Ph.D., Director of its Chemical Biology Program, to design and develop pre-clinical compounds to treat diseases such as rheumatoid arthritis, asthma and inflammatory bowel syndrome... Znomics' Press Release -
Subscribe to:
Posts (Atom)
